CClinicalTrials.gg
WithdrawnNCT04553744Updated Feb 29, 2024

Identification of Surgical Management of Lymph Node Basins and Surgical Practice Patterns Among Sarcoma Surgeons

An observational study in Soft Tissue Sarcoma and Lymph Node Cancer, sponsored by M.D. Anderson Cancer Center. Withdrawn. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-29.

Sponsored by M.D. Anderson Cancer Center · Observational

Why this study was withdrawn
0 participant accrual
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
0
Ages
18 Years and older
Sex
All
01

Study summary

This study investigates the surgical management of lymph node basins for extremity and trunk soft tissue sarcoma (ETSTS) to identify and better understand the surgical practice patterns of sarcoma surgeons. ETSTS has been known to spread to distant locations including lymph nodes, with some subtypes of the disease spreading to lymph nodes more than others. This has led to sarcoma surgeons to treat patients differently from one another, including those with more lymph node involvement. The purpose of this study is to investigate the practice patterns of ETSTS surgeons.

Read the detailed description

PRIMARY OBJECTIVES:

I. Identify the practice patterns of sarcoma surgeons with respect to management of lymph node basins for extremity and trunk soft tissue sarcomas (ETSTS).

II. Identify when surgeons would perform sentinel lymph node biopsy and/or lymph node dissection for ETSTS and if management differs for high-risk subtypes of sarcoma that are more likely to have nodal metastases.

III. Identify differences in practice patterns between surgical oncologists and orthopedic oncologic surgeons.

OUTLINE:

Participants complete an online survey over 5-10 minutes asking how they would manage lymph node basins in the extremity sarcoma.

02

Conditions studied

  • Soft Tissue Sarcoma
  • Lymph Node Cancer

Browse trials for

03

In context

Sarcoma

1,667 studies on the registry are indexed under Sarcoma; 393 are open to participants now.

Browse Sarcoma studies →

Lead sponsor

M.D. Anderson Cancer Center is the lead sponsor of 2,999 studies on the registry; 581 are open to participants now.

Of its 599 completed or terminated interventional studies of FDA-regulated products, 402 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Practicing surgeons who are members of The Society of Surgical Oncology and Musculoskeletal Tumor Society, and treat extremity and trunk soft tissue sarcomas.

Inclusion criteria

  • Currently practicing surgeons who treat ETSTS and are members of The Society of Surgical Oncology and Musculoskeletal Tumor Society

Exclusion criteria

Exclusion Criteria:

None

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
0 participants (actual)

Groups and cohorts

  • Observational (survey)

    Participants complete an online survey over 5-10 minutes asking how they would manage lymph node basins in the extremity sarcoma.

    Other: Survey Administration

Interventions

  • OtherSurvey Administration

    Complete survey

06

What researchers measure

Primary outcomes

  1. Practice patterns of sarcoma surgeons

    Will identify the practice patterns of sarcoma surgeons with respect to management of lymph node basins for extremity and trunk soft tissue sarcomas (ETSTS).

    Time frame: Up to 2 years

  2. Sentinel lymph node biopsy and/or lymph node dissection for ETSTS

    Will identify when surgeons would perform sentinel lymph node biopsy and/or lymph node dissection for ETSTS, and if management differs for high-risk subtypes of sarcoma that are more likely to have nodal metastases.

    Time frame: Up to 2 years

  3. Differences in practice patterns

    Will identify differences in practice patterns between surgical oncologists and orthopedic oncologic surgeons.

    Time frame: Up to 2 years

07

Study locations

No study locations are listed for this record.

08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04553744
Lead sponsor
M.D. Anderson Cancer Center
Collaborators
National Cancer Institute (NCI)
Responsible party
Sponsor
First posted
Sep 17, 2020
Start date
Jun 22, 2020
Primary completion
Feb 26, 2024
Completion
Feb 26, 2024
Last update
Feb 29, 2024

Study contacts

Christina L Roland
principal investigator · M.D. Anderson Cancer Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion